Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Maja Bulatović Ćalasan, Oscar F. C. van den Bosch, M.C.W. Creemers, et al.
Arthritis Research & Therapy (2013) Vol. 15, Iss. 6
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wanying Wang, Hua Zhou, Liang Liu
European Journal of Medicinal Chemistry (2018) Vol. 158, pp. 502-516
Closed Access | Times Cited: 461
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
J. W. J. Bijlsma, Paco M J Welsing, Thasia Woodworth, et al.
The Lancet (2016) Vol. 388, Iss. 10042, pp. 343-355
Closed Access | Times Cited: 219
ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria
Xing‐Xing Fan, Mengze Xu, Elaine Lai‐Han Leung, et al.
Nano-Micro Letters (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 98
Surface-Modified Bilosomes Nanogel Bearing a Natural Plant Alkaloid for Safe Management of Rheumatoid Arthritis Inflammation
Mohammed H. Elkomy, Nabil K. Alruwaili, Mohammed Elmowafy, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 563-563
Open Access | Times Cited: 54
Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease
Leticia León, Alfredo Madrid-García, Patricia Lopez-Viejo, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002842-e002842
Open Access | Times Cited: 18
<p>Drug-related problems in patients with rheumatoid arthritis</p>
Shu Ning, Hasniza Zaman Huri, Fariz Yahya
Therapeutics and Clinical Risk Management (2019) Vol. Volume 15, pp. 505-524
Open Access | Times Cited: 47
Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire)
Nibah Fatimah, Babur Salim, Amjad Nasim, et al.
Clinical Rheumatology (2016) Vol. 35, Iss. 5, pp. 1341-1345
Closed Access | Times Cited: 47
Low prevalence of methotrexate intolerance in rheumatoid arthritis: a South African study
Namuhla Qwabe, Farhanah Paruk, Girish M. Mody
Clinical Rheumatology (2025)
Open Access
A Consensus Report by the RAPID-India Group on Optimising Tofacitinib Treatment for Indian Patients with Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis
de Bisschop G, Oak Jyotsna, Uma Kumar, et al.
Indian Journal of Rheumatology (2025)
Open Access
How to fail successfully
Berent J. Prakken
Journal of Trial and Error (2025)
Open Access
Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study
Josef S Smolen, Paul Emery, William F. C. Rigby, et al.
RMD Open (2025) Vol. 11, Iss. 2, pp. e005051-e005051
Open Access
Gold-Coated Superparamagnetic Iron Oxide Nanoparticles Attenuate Collagen-Induced Arthritis after Magnetic Targeting
Maria Fernanda Hornos Carneiro, Ana Rita Thomazela Machado, Lusânia Maria Greggi Antunes, et al.
Biological Trace Element Research (2019) Vol. 194, Iss. 2, pp. 502-513
Closed Access | Times Cited: 26
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
Carlos Sánchez‐Piedra, Diana Sueiro-Delgado, Javier García‐González, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Assessment of oral methotrexate intolerance in Japanese adult patients with rheumatoid arthritis
Masatoshi Kanda, Mayumi Sato, Ken Nagahata, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 3
Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short‐term study
Pooja Dhaon, Siddharth Kumar Das, R.N. Srivastava, et al.
International Journal of Rheumatic Diseases (2016) Vol. 21, Iss. 5, pp. 1010-1017
Closed Access | Times Cited: 27
Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen
Anand N. Malaviya
Clinical Rheumatology (2016) Vol. 36, Iss. 2, pp. 279-285
Closed Access | Times Cited: 26
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Sonja Falvey, Lauren Shipman, Norman T. Ilowite, et al.
Pediatric Rheumatology (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Chinese traditional medicine (GuiZhi-ShaoYao-ZhiMu decoction) as an add-on medication to methotrexate for rheumatoid arthritis: a meta-analysis of randomized clinical trials
Chenxi Feng, Rongrong Chen, Keer Wang, et al.
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 18
Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis
Ronald Man Lung Yip, Cheuk Wan Yim
JCR Journal of Clinical Rheumatology (2019) Vol. 27, Iss. 8, pp. e516-e524
Open Access | Times Cited: 21
A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology
Ge Wang, Xiao-yan Peng
Journal of Ophthalmology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 20
Methotrexate intolerance in Rheumatoid Arthritis
Harjit Singh Nalwa, Peeyush Prasad, Nirmal Kumar Ganguly, et al.
Translational Medicine Communications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature
Eva Vermeer, Renske C. F. Hebing, Maartje M. van de Meeberg, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 12, pp. 276-284
Open Access | Times Cited: 7
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Camilla Wibrand, Nini Kyvsgaard, Troels Herlin, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 5, pp. 479-498
Open Access | Times Cited: 2
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Andrea Scheuern, Nadine Fischer, Joseph McDonald, et al.
Pediatric Rheumatology (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 19
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Jéssica Martins Amaral, Maria José Menezes Brito, Adriana María Kakehasi
Advances in Rheumatology (2020) Vol. 60, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top